DNAprint Genomics (DNAG)

[SlopsterSlasher]

On Ovarian for God's sake what does this mean -

"Once funding sufficient to screen 250 patients at $1,000 per patient is received, OVANOMETM will be tested in clinical trials for monitoring and reporting on the use of Taxol and Carboplatin. Our Chief Medical Officer, Hector J. Gomez, MD, PhD will lead the clinical development process."

Is this 250 patients just the beginning because thats the # for phase 1 trials and that would mean Ovarian will be years away.

Or is the 250 patients just a final testing ground for a completed product.

And we have to wait for FDA to play catch up where it says in another part of the web site that the FDA wont be ready till 2005 on approving classifiers

THIS SUCKS IM, SORRY I though 2004 maybe 2005 and we have a FDA approved product now it looks like were just starting once we get to 2005.

Good luck everyone